Drugs / CD19-targeting CAR T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02547948 | Sep 2015 → Aug 2016 | lymphoma | Fuda Cancer Hospital, Guangzhou | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD19-targeting CAR T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02547948 ↗ |
| Modality | Cell therapy | “CD19-targeting CAR T Cells infusion” NCT02547948 ↗ |
| Target | CD19 | “Chimeric antigen receptor (CAR) T cells targeting CD19” NCT02547948 ↗ |